THE HYDRUS MICROSTENT – MECHANISMS OF ACTION AND CLINICAL EFFICACY.
Download Whitepaper
THE HYDRUS MICROSTENT – MECHANISMS OF ACTION AND CLINICAL EFFICACY.
- Author:
Dr. GEORGE F. CASTILLO
MIGS devices have the capacity to provide efficacy and reduce complicationswith rapid patient recovery. The HYDRUS Microstent has a Tri-Modal® mechanism of action that bypasses the trabecular meshwork, scaffolds Schlemm’s canal, and spans approximately 90° ensuring access t o collector channels in the nasal region. The pivotal clinical data demonstrate that combining the HYDRUS Microstent with cataract surgery provides a durable decrease in IOP in adults with mild to moderate primary open-angle glaucoma with a concurrent decrease in medication dependence.
